You might know you need to conduct drug metabolism and pharmacokinetic (DMPK) analysis, but which tests are right for your project? And are you doing them at the right time? When building your preclinical strategy, these questions matter—and that’s true now more than ever, as new drug classes and targets emerge.
The Thing About Theranostics…
The landscape of oncology drug development is rapidly evolving, with personalized medicine taking center stage. At the heart of this revolution is ...
American Association of Pharmaceutical Scientists (AAPS) Flow Cytometry Action Programming Committee
By Jennifer J. Stewart, PhD
Why Small Molecules Are Still a Big Deal
In the biotech world, small molecules often get treated like the veteran actor at the awards show – respected, but no longer the star of the night. ...
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
